Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | PYGB | P11216 | 2/20 | 0.38 |
| ▸ | GBA1 | P04062 | 1/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.35 |
| ▸ | PRKCA | P17252 | 6/20 | 0.34 |
| ▸ | GBA2 | Q9HCG7 | 1/20 | 0.34 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.34 |
| ▸ | PRKCG | P05129 | 1/20 | 0.34 |
| ▸ | PRKCB | P05771 | 1/20 | 0.34 |
| ▸ | PRKCH | P24723 | 1/20 | 0.34 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.34 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.34 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.34 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1665805 | 1.00 | MAPK1 (0.44) | MAPK1PYGBGBA1PTPN1PRKCA | |
| SCHEMBL2589263 | 0.88 | MAPK1 (0.38) | MAPK1PYGBPTPN1PRKCAPRKD3 | |
| SCHEMBL2589260 | 0.88 | MAPK1 (0.38) | MAPK1PYGBPTPN1PRKCAPRKD3 | |
| SCHEMBL1279530 | 0.87 | MAPK1 (0.40) | MAPK1PYGBPRKCAGBA2PRKD3 | |
| SCHEMBL17781741 | 0.83 | PYGB (0.43) | MAPK1PYGB | |
| SCHEMBL1173142 | 0.78 | PRKCA (0.39) | MAPK1PYGBPRKCA | |
| SCHEMBL1173608 | 0.78 | PRKCA (0.39) | MAPK1PYGBPRKCA | |
| SCHEMBL28575710 | 0.77 | PYGB (0.48) | PYGB | |
| SCHEMBL5062195 | 0.77 | PYGB (0.48) | PYGB | |
| SCHEMBL5149118 | 0.77 | MAPK1 (0.39) | MAPK1PYGBGBA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8642528-B2 | Alkyl lactyllactates and processes of making the same | STEPAN COMPANY (US) | 2014-02-04 | — | — | US | claimed |
| EP-2444060-A2 | Composition | Stepan Company (US) | 2012-04-25 | — | — | EP | claimed |
| US-20090200511-A1 | Alkyl Lactyllactates and Processes of Making the Same | STEPAN COMPANY | 2009-08-13 | — | — | US | claimed |
| EP-2041064-A2 | ALKYL LACTYLLACTATES AND PROCESSES OF MAKING THE SAME | STEPAN COMPANY (US) | 2009-04-01 | — | — | EP | claimed |
| WO-2008006076-A2 | ALKYL LACTYLLACTATES AND PROCESSES OF MAKING THE SAME | STEPAN COMPANY (US) | 2008-01-10 | — | — | WO | claimed |
| CN-112707941-B | Environment-friendly glycoside zwitterion foaming agent for foam drilling | 中石化南京化工研究院有限公司 | 2023-01-31 | — | — | CN | disclosed |
| CN-112707941-A | Environment-friendly glycoside zwitterion foaming agent for foam drilling | 中石化南京化工研究院有限公司 | 2021-04-27 | — | — | CN | disclosed |
| EP-2444060-B1 | Personal care composition | STEPAN CO (US) | 2017-08-23 | — | — | EP | disclosed |
| EP-2496545-B1 | SULFOMETHYLSUCCINATES, PROCESS FOR MAKING SAME AND COMPOSITIONS CONTAINING SAME | STEPAN CO (US) | 2017-01-11 | — | — | EP | disclosed |
| CN-102712563-B | Sulphur methylsuccinic acid (or its salt), its preparation method and comprise its composition | STEPAN CO. (US) | 2015-11-25 | — | — | CN | disclosed |
| US-9133092-B2 | Alkyl lactyllactates and processes of making the same | STEPAN COMPANY (US) | 2015-09-15 | — | — | US | disclosed |
| US-8853141-B2 | Sulfomethylsuccinates, process for making same and compositions containing same | STEPAN COMPANY (US) | 2014-10-07 | — | — | US | disclosed |
| EP-2041064-B1 | PROCESSES OF MAKING ALKYL LACTYLLACTATES | STEPAN CO (US) | 2012-10-17 | — | — | EP | disclosed |
| CN-102712563-A | Sulfomethylsuccinates, process for making same and compositions containing same | STEPAN CO | 2012-10-03 | — | — | CN | disclosed |
| EP-2496545-A2 | SULFOMETHYLSUCCINATES, PROCESS FOR MAKING SAME AND COMPOSITIONS CONTAINING SAME | Stepan Company (US) | 2012-09-12 | — | — | EP | disclosed |
| EP-2444060-A2 | Composition | Stepan Company (US) | 2012-04-25 | — | — | EP | disclosed |
| WO-2011109047-A2 | SULFOMETHYLSUCCINATES, PROCESS FOR MAKING SAME AND COMPOSITIONS CONTAINING SAME | STEPAN COMPANY (US) | 2011-09-09 | — | — | WO | disclosed |
| US-20090200511-A1 | Alkyl Lactyllactates and Processes of Making the Same | STEPAN COMPANY | 2009-08-13 | — | — | US | disclosed |
| EP-2041064-A2 | ALKYL LACTYLLACTATES AND PROCESSES OF MAKING THE SAME | STEPAN COMPANY (US) | 2009-04-01 | — | — | EP | disclosed |
| WO-2008006076-A2 | ALKYL LACTYLLACTATES AND PROCESSES OF MAKING THE SAME | STEPAN COMPANY (US) | 2008-01-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090200511-A1 | Alkyl Lactyllactates and Processes of Making the Same | LCT, LMAN1, ELOVL6 | MAPK1 3582/4885PYGB 2213/4885GBA1 2901/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.